Growth Metrics

Dna X (SONM) Receivables (2018 - 2025)

Dna X filings provide 8 years of Receivables readings, the most recent being $13.3 million for Q3 2025.

  • On a quarterly basis, Receivables rose 126.7% to $13.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.3 million, a 126.7% increase, with the full-year FY2024 number at $4.5 million, down 82.79% from a year prior.
  • Receivables hit $13.3 million in Q3 2025 for Dna X, up from $9.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $32.0 million in Q3 2023 to a low of $4.5 million in Q4 2024.
  • Median Receivables over the past 5 years was $13.7 million (2024), compared with a mean of $15.3 million.
  • Biggest five-year swings in Receivables: surged 334.93% in 2023 and later tumbled 82.79% in 2024.
  • Dna X's Receivables stood at $15.3 million in 2021, then skyrocketed by 61.31% to $24.7 million in 2022, then increased by 6.33% to $26.3 million in 2023, then tumbled by 82.79% to $4.5 million in 2024, then skyrocketed by 195.11% to $13.3 million in 2025.
  • The last three reported values for Receivables were $13.3 million (Q3 2025), $9.8 million (Q2 2025), and $5.0 million (Q1 2025) per Business Quant data.